Jichi Medical University, Center for Molecular Medicine, Nishimura lab

Our research was born in April 1974 as first department in Japan specializing in the study of thrombosis and hemostasis. Since discovering α2-Plasmin Inhibitor, a regulator of thrombolysis, we have dedicated ourselves to developing diagnostic criteria for disseminated intravascular coagulopathy (DIC) and to analyzing congenital bleeding disorders. We are now conducting research toward the development of a gene therapy for hemophilia, a well-known congenital bleeding disorder.
In August 2013, full professor Satoshi Nishimura joined our research, expanding our studies into the areas of bio-imaging and lifestyle-related diseases arising due to chronic inflammation.